Global Ophthalmology Drugs Market Analysis 2016 - Forecast to 2022

  • ID: 3845828
  • Report
  • Region: Global
  • 127 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Ophthalmology Drugs". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Ophthalmology Drugs Market by Delivery Type
5.1 Introduction
5.2 Eye drops
5.3 Eye Solutions
5.4 Capsules & Tablets
5.5 Eye ointment
5.6 Gels

6 Ophthalmology Drugs Market by Treatment
6.1 Introduction
6.2 Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs
6.2.1 Vigamox / Moxeza
6.2.2 TobraDex
6.2.3 Patanol / Pataday / Opatanol
6.2.4 AzaSite
6.2.5 Bepreve
6.2.6 Xibrom / Bromday
6.3 Dry eye drugs
6.3.1 Diquas
6.3.2 Restasis
6.3.3 Hyalein
6.4 Anti-glaucoma drugs
6.4.1 Alphagan P / Combigan
6.4.2 Azarga
6.4.3 Xalatan / Xalacom
6.4.4 Azopt
6.4.5 Tapros / Saflutan / Taflotan
6.4.6 Cosopt / Trusopt
6.4.7 Lumigan
6.5 Retinal disorders
6.5.1 Avastin (Off-label)
6.5.2 Lucentis
6.5.3 Eylea
6.5.4 Visudyne

7 Geographical Segmentation
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 RoW
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiles
9.1 Pfizer Inc
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financial Overview
9.1.4 Strategy
9.1.5 Key Activities
9.2 Hoya Corporation
9.3 Bayer
9.4 Novartis International AG
9.5 Abbott Medical Optics, Inc.
9.6 Ziemer Ophthalmic Systems AG
9.7 Regeneron
9.8 Johnson & Johnson Vision Care, Inc.
9.9 Bausch & Lomb Inc.
9.10 Topcon Corporation
9.11 Ellex Medical Lasers Ltd.
9.12 Alcon Inc.
9.13 Merck & Co., Inc
9.14 Spark Therapeutics
9.15 Insight Vision Inc.
9.16 Roche Holding Ltd
9.17 Ophthotech
9.18 Novagali Pharma S A
9.19 Allergan, Inc.
9.20 Carl-Zeiss AG
9.21 Santen
9.22 Essilor International S.A.

10 Appendix
11 Disclaimer

List of Tables
Table 1 Global Ophthalmology Drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Ophthalmology Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 3 Global Eye drops Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Eye drops Market Analysis, by Treatment, 2013-2022 ($MN)
Table 5 Global Eye Solutions Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Eye Solutions Market Analysis, by Treatment, 2013-2022 ($MN)
Table 7 Global Capsules & Tablets Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Capsules & Tablets Market Analysis, by Treatment, 2013-2022 ($MN)
Table 9 Global Eye Ointment Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Eye Ointment Market Analysis, by Treatment, 2013-2022 ($MN)
Table 11 Global Gels Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Gels Market Analysis, by Treatment, 2013-2022 ($MN)
Table 13 Global Ophthalmology Drugs Market Analysis, by Treatment, 2013-2022 ($MN)
Table 14 Global Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 15 Global Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 16 Global Dry eye drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 17 Global Dry eye drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 18 Global Anti-glaucoma drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 19 Global Anti-glaucoma drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 20 Global Retinal disorders Market Analysis, by Region, 2013-2022 ($MN)
Table 21 Global Retinal disorders Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 22 North America Ophthalmology Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 23 North America Ophthalmology Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 24 North America Eye drops Market Analysis, by Country, 2013-2022 ($MN)
Table 25 North America Eye drops Market Analysis, by Treatment, 2013-2022 ($MN)
Table 26 North America Eye Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 27 North America Eye Solutions Market Analysis, by Treatment, 2013-2022 ($MN)
Table 28 North America Capsules & Tablets Market Analysis, by Country, 2013-2022 ($MN)
Table 29 North America Capsules & Tablets Market Analysis, by Treatment, 2013-2022 ($MN)
Table 30 North America Eye Ointment Market Analysis, by Country, 2013-2022 ($MN)
Table 31 North America Eye Ointment Market Analysis, by Treatment, 2013-2022 ($MN)
Table 32 North America Gels Market Analysis, by Country, 2013-2022 ($MN)
Table 33 North America Gels Market Analysis, by Treatment, 2013-2022 ($MN)
Table 34 North America Ophthalmology Drugs Market Analysis, by Treatment, 2013-2022 ($MN)
Table 35 North America Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 36 North America Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 37 North America Dry eye drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 38 North America Dry eye drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 39 North America Anti-glaucoma drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 40 North America Anti-glaucoma drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 41 North America Retinal disorders Market Analysis, by Country, 2013-2022 ($MN)
Table 42 North America Retinal disorders Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 43 Europe Ophthalmology Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 44 Europe Ophthalmology Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 45 Europe Eye drops Market Analysis, by Country, 2013-2022 ($MN)
Table 46 Europe Eye drops Market Analysis, by Treatment, 2013-2022 ($MN)
Table 47 Europe Eye Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 48 Europe Eye Solutions Market Analysis, by Treatment, 2013-2022 ($MN)
Table 49 Europe Capsules & Tablets Market Analysis, by Country, 2013-2022 ($MN)
Table 50 Europe Capsules & Tablets Market Analysis, by Treatment, 2013-2022 ($MN)
Table 51 Europe Eye Ointment Market Analysis, by Country, 2013-2022 ($MN)
Table 52 Europe Eye Ointment Market Analysis, by Treatment, 2013-2022 ($MN)
Table 53 Europe Gels Market Analysis, by Country, 2013-2022 ($MN)
Table 54 Europe Gels Market Analysis, by Treatment, 2013-2022 ($MN)
Table 55 Europe Ophthalmology Drugs Market Analysis, by Treatment, 2013-2022 ($MN)
Table 56 Europe Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 57 Europe Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 58 Europe Dry eye drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 59 Europe Dry eye drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 60 Europe Anti-glaucoma drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 61 Europe Anti-glaucoma drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 62 Europe Retinal disorders Market Analysis, by Country, 2013-2022 ($MN)
Table 63 Europe Retinal disorders Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 64 Asia Pacific Ophthalmology Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 65 Asia Pacific Ophthalmology Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 66 Asia Pacific Eye drops Market Analysis, by Country, 2013-2022 ($MN)
Table 67 Asia Pacific Eye drops Market Analysis, by Treatment, 2013-2022 ($MN)
Table 68 Asia Pacific Eye Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 69 Asia Pacific Eye Solutions Market Analysis, by Treatment, 2013-2022 ($MN)
Table 70 Asia Pacific Capsules & Tablets Market Analysis, by Country, 2013-2022 ($MN)
Table 71 Asia Pacific Capsules & Tablets Market Analysis, by Treatment, 2013-2022 ($MN)
Table 72 Asia Pacific Eye Ointment Market Analysis, by Country, 2013-2022 ($MN)
Table 73 Asia Pacific Eye Ointment Market Analysis, by Treatment, 2013-2022 ($MN)
Table 74 Asia Pacific Gels Market Analysis, by Country, 2013-2022 ($MN)
Table 75 Asia Pacific Gels Market Analysis, by Treatment, 2013-2022 ($MN)
Table 76 Asia Pacific Ophthalmology Drugs Market Analysis, by Treatment, 2013-2022 ($MN)
Table 77 Asia Pacific Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 78 Asia Pacific Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 79 Asia Pacific Dry eye drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 80 Asia Pacific Dry eye drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 81 Asia Pacific Anti-glaucoma drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 82 Asia Pacific Anti-glaucoma drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 83 Asia Pacific Retinal disorders Market Analysis, by Country, 2013-2022 ($MN)
Table 84 Asia Pacific Retinal disorders Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 85 RoW Ophthalmology Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 86 RoW Ophthalmology Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 87 RoW Eye drops Market Analysis, by Country, 2013-2022 ($MN)
Table 88 RoW Eye drops Market Analysis, by Treatment, 2013-2022 ($MN)
Table 89 RoW Eye Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 90 RoW Eye Solutions Market Analysis, by Treatment, 2013-2022 ($MN)
Table 91 RoW Capsules & Tablets Market Analysis, by Country, 2013-2022 ($MN)
Table 92 RoW Capsules & Tablets Market Analysis, by Treatment, 2013-2022 ($MN)
Table 93 RoW Eye Ointment Market Analysis, by Country, 2013-2022 ($MN)
Table 94 RoW Eye Ointment Market Analysis, by Treatment, 2013-2022 ($MN)
Table 95 RoW Gels Market Analysis, by Country, 2013-2022 ($MN)
Table 96 RoW Gels Market Analysis, by Treatment, 2013-2022 ($MN)
Table 97 RoW Ophthalmology Drugs Market Analysis, by Treatment, 2013-2022 ($MN)
Table 98 RoW Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 99 RoW Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 100 RoW Dry eye drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 101 RoW Dry eye drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 102 RoW Anti-glaucoma drugs Market Analysis, by Country, 2013-2022 ($MN)
Table 103 RoW Anti-glaucoma drugs Market Analysis, by Delivery Type, 2013-2022 ($MN)
Table 104 RoW Retinal disorders Market Analysis, by Country, 2013-2022 ($MN)
Table 105 RoW Retinal disorders Market Analysis, by Delivery Type, 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll